This study investigates pancreatic adenocarcinoma. It focuses on comparing two different methods of administering chemotherapy following radiotherapy.
The study evaluates the safety and effectiveness of intra-arterial chemotherapy compared to the standard intravenous chemotherapy for patients with this condition.
- Who can participate: Adults aged 18 and older with confirmed pancreatic adenocarcinoma that is locally advanced and unresectable can participate.
- Study details: Participants will receive investigational medication and radiotherapy. Some will be given an investigational medication directly into the arteries, while others will continue with standard IV investigational medication.